Nifty 50 Index Dips 0.29% While Pharma Sector Slides 1.6% In Pre-Open Trade

India's key stock benchmark, the Nifty 50 index, showed signs of pressure, declining 0.29% in pre-open trade on September 26, 2025. The broader market sentiment reflected cautious investor behavior, influenced by lingering uncertainties across global and domestic fronts. The sectoral Nifty Pharma index, in particular, was notably weaker, falling 1.6% ahead of the market open.

Market Overview And Sentiment

The Nifty 50 index was trading under pressure, signaling possible continuation of cautious trading amid global macroeconomic concerns.

Investor focus remained sensitive to foreign fund flows and developments related to recent US tariff announcements impacting Indian exporters, including pharma companies.

The Pharma index faced sharper selling, reflecting worries around tariff-led headwinds and regulatory risks in the sector.

Sectoral Impact And Trade Dynamics

Pharma stocks struggled in pre-market activity due to threats of rising import costs, particularly from the 100% US tariffs on branded pharmaceutical drugs. Companies heavily reliant on US exports are seen vulnerable to margin pressure and revenue impact. Conversely, other sectors like IT and banking showed relative resilience but remained subdued due to profit booking.

Global Cues And Domestic Factors

US markets declined in the previous session as investors digested robust GDP growth data and jobless claims, which cast doubt on the timing of Federal Reserve rate cuts.

Concerns over prolonged foreign institutional investor outflows from Indian markets also weighed on sentiment, contributing to the subdued start.

Outlook For The Trading Session

Going into the session, analysts expect volatility to remain elevated, with the Nifty 50 likely to trade within a range, testing support near 24,575 and resistance around 25,000. The Pharma index may continue facing pressure until clarity emerges on trade policy and tariff mitigation.

Investors are advised to monitor global developments closely alongside domestic corporate earnings to navigate near-term market volatility.

Sources: NSE India, Economic Times, Bloomberg, Moneycontrol